McKesson Corp. (NYSE: MCK), San Francisco, CA, has agreed to acquire Rexall Health from Katz Group, Edmonton, Alberta, for C$3 billion (US$2.2 billion), strengthening McKesson’s position in Canada’s pharmaceutical supply chain.
“The acquisition of Rexall Health supports McKesson’s commitment to drive value in the industry by improving health care solutions delivered in the pharmacy; it enhances our ability to provide best-in-class pharmacy care through an expanded retail footprint for patients across Canada,” said John H. Hammergren, McKesson CEO.
